- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04420910
Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson's Disease
Investigation of Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson's Disease
The purposes of this study is to examine balance, muscle strength, and mobility in relation with non-motor symptoms (NMSs) in patients with Parkinsosn's Disease (PD).
NMSs have been shown to be the key determinant of health-related quality of life (HRQoL) and have a greater effect on HRQoL compared to motor symptoms.Despite a growing literature on NMSs, there are few data on the association between NMSs and motor phenotypes of PD, and they have usually focused only on specific domains of NMSs, such as cognition, mood/anxiety issues, or sleep disorders.
When literature is examined, there is no study which examines balance, muscle strength, and mobility in relation with NMSs in patients with PD.For all these reasons, we think that balance, muscle strength, mobility, and NMSs in patients with PD are worse than those of the healthy individuals and that there is a relationship between NMSs and motor symptoms.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Esenboğa
-
Ankara, Esenboğa, Turkey, 06970
- Ankara Yıldırım Beyazıt University, Faculty of Health Sciences,Department of Physiotherapy and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- being diagnosed with PD by a neurologist, being in Hoehn & Yahr Stage 1-3, having no musculoskeletal system problems in the previous 6 months, having a score of 24 or more in the Mini-Mental State Examination (MMSE), and being volunteer.
Exclusion Criteria:
- Healthy individuals of similar age and sex, without neurological problems, and who did not experience any musculoskeletal system problems in the previous 6 months were included in the control group.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Parkinson's disease group
being diagnosed with PD by a neurologist, being in Hoehn & Yahr Stage 1-3
|
NMSs of the participants were evaluated using the Non-Motor Symptoms Scale (NMSS).
The scale consists of 30 yes-no questions and is administered face to face with the therapist.
To measure balance, the Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) was used.
The participants were asked to position themselves in a comfortable position on the platform, and their foot position coordinates were recorded.
The participants focused on a characteristic dot on the monitor screen.
Their task was to balance the body in such a way that the dot was in the center of a circle displayed on the monitor at the point of intersection of the coordinate axes.
The test consisted of three 20 s trials, each separated by 10 s breaks.
Measurements were conducted while their eyes were open and close, and the results were analyzed by calculating the average value of the measurements.
A Biodex® System 4 Dynamometer device was used to evaluate muscle strength.
The participants' dominant extremity was determined by asking them the foot with which they most often hit the ball.The dynamometer arm of the device was placed at the lateral condyle level of the knee, and the belt at the distal end of the dynamometer was attached to the lower leg on the malleolus.
Knee flexion and extension movements were evaluated in sitting position between 90ᵒ flexion and 0ᵒ extension angles.
The individual was asked to perform it with the maximum strength, while the therapist motivated the individual with verbal stimulation.
The Timed Up and Go test (TUG) was used in the evaluation of functional mobility. .
For this test, participants were seated on a standard armless chair and a cone was placed 3 meters away from the chair.
Participants were instructed to stand up and (1) walk towards the cone, (2) turn around the cone, (3) walk back to the chair, and (4) sit back on the chair.
It was stated that patients should walk without running but as fast as possible.
Dual task performance was performed by adding cognitive and motor tasks into the TUG.
|
Healthy group
20 healthy volunteers with matching ages and genders.
|
NMSs of the participants were evaluated using the Non-Motor Symptoms Scale (NMSS).
The scale consists of 30 yes-no questions and is administered face to face with the therapist.
To measure balance, the Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) was used.
The participants were asked to position themselves in a comfortable position on the platform, and their foot position coordinates were recorded.
The participants focused on a characteristic dot on the monitor screen.
Their task was to balance the body in such a way that the dot was in the center of a circle displayed on the monitor at the point of intersection of the coordinate axes.
The test consisted of three 20 s trials, each separated by 10 s breaks.
Measurements were conducted while their eyes were open and close, and the results were analyzed by calculating the average value of the measurements.
A Biodex® System 4 Dynamometer device was used to evaluate muscle strength.
The participants' dominant extremity was determined by asking them the foot with which they most often hit the ball.The dynamometer arm of the device was placed at the lateral condyle level of the knee, and the belt at the distal end of the dynamometer was attached to the lower leg on the malleolus.
Knee flexion and extension movements were evaluated in sitting position between 90ᵒ flexion and 0ᵒ extension angles.
The individual was asked to perform it with the maximum strength, while the therapist motivated the individual with verbal stimulation.
The Timed Up and Go test (TUG) was used in the evaluation of functional mobility. .
For this test, participants were seated on a standard armless chair and a cone was placed 3 meters away from the chair.
Participants were instructed to stand up and (1) walk towards the cone, (2) turn around the cone, (3) walk back to the chair, and (4) sit back on the chair.
It was stated that patients should walk without running but as fast as possible.
Dual task performance was performed by adding cognitive and motor tasks into the TUG.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Non-Motor Symptoms
Time Frame: one hour
|
Non-motor symptoms of the participants were evaluated using the Non-Motor Symptoms Scale (NMSS).Each item of the scale is scored between 0 and 30, with "yes" 1 point and "no" 0 point.
According to the scoring result, "0" indicates no NMSs, "1-5" indicates mild NMSs, "6-9" indicates medium NMSs, "10-13" indicates heavy NMSs, and "≥14" indicates very heavy NMSs.
|
one hour
|
Balance
Time Frame: one hour
|
To measure balance, the Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) was used.The test consisted of three 20 s trials, each separated by 10 s breaks.
Measurements were conducted while their eyes were open and close, and the results were analyzed by calculating the average value of the measurements.
As a result, overall stability and anteroposterior and mediolateral indexes were taken into account, and low values indicate high postural stability.
|
one hour
|
Lower limb strength
Time Frame: one hour
|
A Biodex® System 4 Dynamometer device was used to evaluate muscle strength.Maximal concentric knee flexion and extension muscle strength was measured at 90 degrees/sec angular velocity with 5 repetition [19].
The flexion and extension peak torque (PT) values, peak torque/body weight (PT/BW) ratio, and hamstring/quadriceps (H/Q) ratio were recorded.
Low values indicate decreased muscle strength.
|
one hour
|
Functional mobility
Time Frame: one hour
|
The Timed Up and Go test (TUG) was used in the evaluation of functional mobility.
Dual task performance was performed by adding cognitive and motor tasks into the TUG..
As the time increases, dual task performance decreases.
|
one hour
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-71
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Non-Motor Symptoms
-
City, University of LondonKing's College London; King's College Hospital NHS TrustCompletedParkinson DiseaseUnited Kingdom
-
Assistance Publique Hopitaux De MarseilleCompleted
-
University Hospital TuebingenRecruitingHereditary Spastic Paraplegia | Hereditary, Spastic Paraplegia, Autosomal DominantGermany
-
Clare MaguireRehab Basel; Bildungszetrum Gesundheit Basel-StadtCompleted
-
Centro Universitario La SalleUnknown
-
Vanderbilt University Medical CenterVanderbilt Institute for Clinical and Translational ResearchCompletedNervous System Diseases | Neurologic Manifestations | Movement Disorders | Neuromuscular Manifestations | Cervical Dystonia | Focal Dystonia | Signs and Symptoms | Spasmodic TorticollisUnited States
-
University of AlcalaCompleted
-
Ain Shams UniversityRecruitingParkinson Disease | Cognitive Dysfunction | BiomarkersEgypt
-
IRCCS San RaffaeleCasa di Cura del Policlinico di MilanoRecruiting